Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$648,811,716
-$203,765,612 QoQ
Shares Held
2,578,333
-34.2% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#69
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $648,811,716 | 2,578,333 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $852,577,328 | 3,920,076 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $950,636,300 | 4,160,516 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $985,973,032 | 4,258,327 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $693,441,979 | 3,735,815 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $675,361,529 | 3,223,375 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $478,407,315 | 2,692,219 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $729,645,153 | 3,694,780 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $608,985,190 | 3,550,520 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $632,619,041 | 3,474,020 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $210,297,853 | 1,357,023 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $169,266,573 | 1,135,560 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $148,213,643 | 1,100,079 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $176,275,969 | 1,106,080 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $146,901,873 | 908,990 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $121,303,829 | 903,836 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $143,076,864 | 934,166 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $157,404,756 | 970,975 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $136,960,214 | 1,011,523 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $111,465,954 | 1,033,336 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $118,550,896 | 1,052,476 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $119,655,065 | 1,105,665 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $114,116,464 | 1,065,016 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $88,631,619 | 1,011,892 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $85,911,328 | 875,039 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $64,681,957 | 848,956 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||